Skip to main content

Month: July 2024

Pacific Financial Corp Earns $2.1 Million, or $0.21 per Diluted Share, for Second Quarter 2024; Net Interest Margin Remains Strong During the Second Quarter at 4.15%; Board of Directors Declares Quarterly Cash Dividend of $0.14 per Share

ABERDEEN, Wash., July 26, 2024 (GLOBE NEWSWIRE) — Pacific Financial Corporation (OTCQX: PFLC), (“Pacific Financial”) or the (“Company”), the holding company for Bank of the Pacific (the “Bank”), reported net income of $2.1 million, or $0.21 per diluted share for the second quarter of 2024, compared to $2.7 million, or $0.26 per diluted share for the first quarter of 2024, and $3.9 million, or $0.37 per diluted share for the second quarter of 2023. All results are unaudited. Pacific Financials’ second quarter 2024 operating results reflected the following changes from the first quarter of 2024: (1) lower net interest income as deposit costs increased; (2) higher provision for credit losses due primarily to a larger loan portfolio and changes in the economic forecast and assumptions; (3) higher non-interest income due to larger gains...

Continue reading

Great Pacific Gold Completes Phase 2 Sampling Program at Kesar Creek Project in Papua New Guinea

VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) — Great Pacific Gold Corp. (“Great Pacific Gold,” “GPAC,” or the “Company”) (TSXV: GPAC) (OTCQX: FSXLF) (Germany: 4TU) is pleased to announce the completion of the Phase 2 soil and chip sampling program at the Kesar Creek Project in Papua New Guinea (see Figure 1).    Highlights:667 soil samples and 8 rock chip samples collected during this phase of work Kesar Creek Project is short distance from multiple epithermal vein and porphyry deposits and targets identified on the adjacent K92 Mining Inc. project (see Figure 2). Previous assays from GPAC sampling include multiple high-grade gold results obtained from veins that align with the orientation and strike of K92 Mining Inc.’s prolific Kora Deposit of 2.3 M Oz at 10.24 g/t Au equivalent Measured and...

Continue reading

OneMedNet Announces $4.6 Million Private Placement

Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management MINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“RWD”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has entered into securities purchase agreements with certain institutional investors, including an affiliate of Off the Chain Capital and an affiliate of Discovery Capital Management, in a private placement that resulted in gross proceeds of approximately $4.6 million, before deducting fees and expenses payable by the Company. The private placement closed on July 25, 2024. The price per share of common stock sold in this offering...

Continue reading

Red River Bancshares, Inc. Reports Second Quarter 2024 Financial Results

ALEXANDRIA, La., July 26, 2024 (GLOBE NEWSWIRE) — Red River Bancshares, Inc. (the “Company”) (Nasdaq: RRBI), the holding company for Red River Bank (the “Bank”), announced today its unaudited financial results for the second quarter of 2024. Net income for the second quarter of 2024 was $8.0 million, or $1.16 per diluted common share (“EPS”), a decrease of $201,000, or 2.5%, compared to $8.2 million, or $1.16 EPS, for the first quarter of 2024, and a decrease of $981,000, or 10.9%, compared to $9.0 million, or $1.25 EPS, for the second quarter of 2023. For the second quarter of 2024, the quarterly return on assets was 1.05%, and the quarterly return on equity was 10.69%. Net income for the six months ended June 30, 2024, was $16.2 million, or $2.31 EPS, a decrease of $2.4 million, or 12.9%, compared to $18.6 million, or $2.58 EPS,...

Continue reading

Webuy Receives Extension to Regain Compliance with Nasdaq’s Minimum Bid Requirements

Singapore, July 26, 2024 (GLOBE NEWSWIRE) —  Webuy Global Ltd. (Nasdaq: WBUY) (“Webuy” or the “Company”), a Southeast Asian community e-commerce retailer, today announced that, following the receipt of a written notice from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq”) on January 26, 2024 regarding the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”) for continued listing on the Nasdaq Capital Market, it received written notification from Nasdaq, providing an additional 180 calendar days, or until January 21, 2025, to regain compliance with the minimum bid price of U.S. $1.00, as required by Nasdaq Listing Rule. Under Nasdaq Listing Rule 5810(c)(3)(A), if at any time over this period the bid price of Webuy’s shares closes at U.S. $1.00 per share...

Continue reading

ProMIS Neurosciences Announces Up to $122.7 Million Private Placement Financing

$30.3 million financing upfront with up to an additional $92.4 million tied to exercise of warrants, with certain of the warrants subject to shareholder approval Fundraise supports development of novel antibody PMN310 for Alzheimer’s Disease patients Proceeds expected to support Company beyond 6 month and 12 month data from the PMN310 Phase Ib study in Alzheimer’s patients TORONTO, Ontario and CAMBRIDGE, Massachusetts, July 26, 2024 (GLOBE NEWSWIRE) — ProMIS Neurosciences Inc. (Nasdaq: PMN) (“ProMIS” or the “Company”), a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), today announced that it has entered into a unit purchase...

Continue reading

Nutraceutical Market to Reach USD 868.38 Billion by 2031

Westford, USA, July 26, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Nutraceuticals Market will attain a value of USD 868.38 Billion by 2031, with a CAGR of 9.50 % during the forecast period (2024-2031). There are many factors that are boosting the market growth of nutraceuticals such as preventive healthcare, rising instances of lifestyle-related problems, and consumer focus on healthy diets. The increasing number of consumer spending power in developing economies is also promoting the demand for nutraceuticals products. As people are becoming more conscious about their diets and trying to opt for self-directed cate for treating lifestyles problems like cardiovascular disorders and malnutrition, the demand for dietary supplements and nutraceuticals will continue to rise. Nutraceuticals are also related to many medical health...

Continue reading

Purpose Investments Inc. Announces Final July 2024 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

TORONTO, July 26, 2024 (GLOBE NEWSWIRE) — Purpose Investments Inc. announced today the final July 2024 distribution rates for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund. The following table reflects the final distribution amounts for the month of June. Ex-distribution date is July 29, 2024.Open-End Fund Ticker Symbol Final distribution per unit Record Date Payable Date Distribution FrequencyPurpose USD Cash Management Fund – ETF Units MNU.U US $ 0.4831 07/29/2024 08/02/2024 MonthlyPurpose Cash Management Fund – ETF Units MNY $ 0.4398 07/29/2024 08/02/2024 MonthlyPurpose High Interest Savings Fund – ETF Units PSA $ 0.2108 07/29/2024 08/02/2024 MonthlyPurpose US Cash Fund – ETF Units PSU.U US $ 0.4675 07/29/2024 08/02/2024 MonthlyAbout...

Continue reading

TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million

Scienture, Inc., a private branded and specialty pharmaceutical company, entered into a business combination with TRxADE Health Inc., in an all-stock transaction valued at $103 million. TAMPA, FL and COMMACK, NY, July 26, 2024 (GLOBE NEWSWIRE) — TRxADE HEALTH, INC. (“TRxADE”) (Nasdaq: MEDS) and Scienture, Inc. (“Scienture”) today announced the closing of TRxADE’s business combination with Scienture in an all-stock transaction (the “Business Combination”). TRxADE acquired all of Scienture’s assets in exchange for shares of TRxADE stock, in a combination of common stock and non-voting convertible preferred stock. TRxADE will change its name to “Scienture Holdings, Inc.” subsequent to the future conversion of the non-voting convertible preferred stock and the combined company is intended to continue as a Nasdaq-listed company. The...

Continue reading

JBTC Announces 2nd Quarter 2024 Earnings

JONESTOWN, Pa., July 26, 2024 (GLOBE NEWSWIRE) — JBT Bancorp, Inc. (OTCQX: JBTC) reported quarterly earnings of $2,167,000 or $0.89 per share for the second quarter of 2024. Six-month reported earnings are $3,474,000 or $1.43 per share, up from $3,394,000 or $1.39 per share in the prior year, representing a 2.36% increase in earnings. President & CEO Troy A. Peters stated: “Our earnings increase was primarily driven by our ability to positively manage our net interest income performance, even during a period of rising funding costs.” More information can be found at OTC Markets at www.otcmarkets.com/stock/JBTC/overview. Contact: Andrea Shetterly, EAAashetterly@jbt.bankJonestown Bank & Trust Co. 2 West Market StreetJonestown, PA 17038-0717Phone: 717-865-4246  

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.